# Retinal degeneration in spinocerebellar ataxia type 7: an overview of the current knowledge

## TL;DR

This paper reviews what is known about retinal degeneration in spinocerebellar ataxia type 7, a rare inherited neurodegenerative disorder.

## Contribution

The paper provides an updated overview of the genetic and molecular mechanisms of retinal degeneration in spinocerebellar ataxia type 7.

## Key findings

- Spinocerebellar ataxia type 7 is strongly indicated by cerebellar ataxia and cone-rod retinal dystrophy.
- Recent advances in genetics have improved understanding of the disease's retinal degeneration and potential therapies.
- The study highlights implications for pathogenesis, clinical features, and possible treatment strategies.

## Abstract

Spinocerebellar ataxia type 7 is a form of spinocerebellar ataxia, which is a
clinically and genetically heterogeneous group of rare inherited
neurodegenerative disorders. Among the spinocerebellar ataxias, the association
between cerebellar ataxia and cone-rod retinal dystrophy is a strong indicator
of spinocerebellar ataxia type 7. Spinocerebellar ataxia type 7 cone-rod
dystrophy is a progressive, disabling, and incurable form of hereditary
retinopathy. However, the field of genetics has markedly progressed in the last
decades, which resulted in improved understanding of multiple aspects of
spinocerebellar ataxia type 7 retinal degeneration and the emergence of new
modalities of genetic therapies for other types of retinal dystrophies. This
study aimed to evaluate the current knowledge on spinocerebellar ataxia type 7
retinal degeneration, including genetics and molecular mechanisms as well as
their implications in pathogenesis, clinical manifestations, and potential
therapeutic strategies.